• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Patient login
Provider login
MiiSkin
Start consultation

      • California
      • Texas
      • Florida
      • New York
      • Pennsylvania
      • Illinois
      • North Carolina
      • Ohio
      • All states

      • Acne treatment
      • Anti-aging treatment
      • Melasma treatment
      • Hyperpigmentation
      • Hair loss treatment
      • Start consultation
      • Tretinoin prescription
      • Spironolactone prescription
      • Latisse prescription
      • Minoxidil prescription
      • Isotretinoin (Accutane) prescription
      • Dutasteride prescription
      • Miiskin App
      • Face & Acne Tracking
      • Mole & Skin Tracking
      • FAQ
      • Patient Stories
      • Acne medicines
      • Anti-aging
      • Hair Loss
      • Hyperpigmentation
      • Dermatology
      • Melanoma
      • Psoriasis
      • Skin cancer
      • Skin conditions
      • Telehealth
      • Tretinoin
      • Accutane

      • Patient Engagement
      • Provider Portal
      • Pricing
      • FAQ
      • Schedule a demo
      • Provide care with Miiskin
      • Dermatologists using Miiskin
      • For Social Media Dermatologists
      • Media coverage
      • Dermatology
      • Telehealth
      • Healthcare
      • Clinic Setup
      • Conferences
      • Software
      • Teledermatology
      • SAF Telehealth
      • Dermatology Apps
Home / About Miiskin / Dermatology research press release

Miiskin Makes Skin Tracking Platform Available for Academic Research, Facilitating New Breakthroughs in Skin Cancer and Dermatology

Miiskin’s teledermatology platform with store and forward image capabilities now freely available for academic dermatological research

miiskin pro tool for dermatologists

DENMARK, May 16, 2022 — Miiskin, a digital health platform helping more than 700,000 people worldwide to routinely monitor their skin and request digital skin evaluations with a provider, has opened its platform to give academic researchers free access, supporting digital collaboration within new dermatology research. This research capability is aiding to advance developments in skin cancer and other dermatological conditions, such as wound care, rosacea, acne, psoriasis, and eczema, along with clinical questionnaires for research subjects.

Miiskin’s platform gives study participants the ability to take high-resolution photos on a smartphone that are then securely stored on the HIPAA-compliant platform and easily shared with researchers. The app utilizes the latest in AI and machine learning to streamline the process and catch abnormalities that the naked eye might miss. Initially launched for the fight against skin cancer, Miiskin is widely accepted by the dermatology community and recently launched a teledermatology platform, Miiskin PRO.

The ability for academic researchers to connect digitally with participants in the study will increase collaboration while harnessing more accurate results, as images can be captured and compared anytime, anywhere – as opposed to having to schedule in-person evaluations to see what results and side effects might result.

”It is clear that Miiskin has unique capabilities in patient engagement within digital dermatology. Its engaging functionality and utilization of AI and machine learning make it a cutting-edge platform available to all. This clinical trial examining the health disparities associated with melanoma care presents the potential for increased effectiveness with the use of Miiskin, resulting in improved quality of data and behaviors critical to the study.”

– Azizi Seixas, Ph.D.,
Associate Professor and Director of the Media and Innovation Lab at the University of Miami Department of Psychiatry and Behavioral Sciences.

“Our teledermatology platform launched last year for dermatologists, and has proven to be a valuable tool in the treatment of various skin conditions, due to the quality of images and ability to share them securely with a clinic. This new interest to use the platform for academic researchers to digitally connect with research subjects is exciting and allows us the opportunity to put this technology for the greater good in dermatology advancements.” 

– Jon Friis, founder of Miiskin

About Miiskin

Founded in Denmark, Miiskin is the first AI-powered smartphone app that helps users track moles and chronic skin conditions over time. It is the most popular consumer skin tracking platform in the world, with 700,000 users, and is widely recommended by the dermatology community (170 clinical partners). The app can be used as a personal tool or in combination with Miiskin PRO, a teledermatology platform that helps deliver prioritized skin healthcare. 

Miiskin is a member of The Skin Cancer Foundation’s Corporate Council and is proud to support the organization’s efforts to educate people about the importance of skin cancer early detection.

Deploying the latest in machine learning, computer vision, and augmented reality, Miiskin reminds and empowers users to take individual and full-body photographs of the skin. Miiskin is the first skin tracking app in The Skin Cancer Foundation’s Corporate Council. Miiskin can be downloaded from the App Store and Google Play, with advanced features available for a 30-day trial. For more information, visit https://miiskin.com.

Media Contacts

AM Public Relations for Miiskin

Erika Beerbower
[email protected] 

Miiskin Logo

  • Facebook
  • Twitter
  • Pinterest

App Store Moles App

Google Play Moles App

Popular skin medications

Tretinoin online prescription

Minoxidil prescription online

Online finasteride prescription

Isotretinoin (Accutane) prescription

Tretinoin 0.1 % Cream prescription

Spironolaction prescription

Service

Find a dermatologist

Acne treatment

Anti-aging treatment

Hair loss treatment

Treatments for skin conditions

Apostrophe alternative

Company

About Miiskin

Educational Content

Media Kit & News

Contact

Careers

Visit the Mexican website

Miiskin is an online dermatology consultations platform that connects patients with independent dermatologists.

All consultations are provided by independent online dermatologists on a cash-pay-only basis. Miiskin does not practice medicine or pharmacy. Prescriptions, if applicable, are sent to third-party pharmacies. Medication images on the website are for illustrative purposes only and images of people are not actual patients. Medical information on miiskin.com is for informational purposes and not medical advice. Consult a healthcare provider for any concerns.

Verify Approval for Miiskin.com HIPAA Compliance Verification - Miiskin.com


Terms of Service · Privacy Policy · Cookie Policy · Miiskin © 2025